xadago(safinamide mesylate)Medication DetailsMDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.Usage: XADAGO is indicated as an adjunctive treatment to levodopa/carbidopa for patients with Parkinson's disease experiencing "off" episodes.Medication DetailsDrug Interactions